Proteomics Intl Labs Ltd has released a press release.
June 2021 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Proteomics engages Abcam to manufacture PromarkerD reagents
- Study shows diabetes drug improves PromarkerD risk scores
- Reinstatement to Official Quotation
- Suspension from Official Quotation
- Modelling shows PromarkerD could save US payers $384 billion
Later from Proteomics International Laboratories
- Proteomics to collaborate to validate test for endometriosis
- Proteomics contracts Biotem to manufacture PromarkerD kits
- Clinical utility study shows benefit of PromarkerD testing
- September 2021 Quarterly Activities Report and Appendix 4C
- Proteomics awarded $100,000 manufacturing funding
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories